LeMaitre Vascular Inc (LMAT) - Product Pipeline Analysis, 2018 Update

Summary

LeMaitre Vascular Inc (LeMaitre Vascular) provides medical devices and services for the treatment of peripheral vascular diseases. The company develops, manufactures, and markets both disposable and implantable devices that vascular surgeons use in arteries and veins outside the heart in open vascular surgeries and minimally invasive procedures. Its product portfolio includes angioScopes, balloon catheters, carotid shunts, radiopaque tapes, powered phlebectomy devices, valvulotomes, remote endarterectomy devices, vascular grafts, patches and closure systems. It also offers human tissue cryopreservation services. LeMaitre Vascular sells its products through a direct sales force in North America, Europe, Asia and Australia and through distributors in other geographies. The company and its subsidiaries operate in the US, Germany, Japan, France, Spain, Italy, Canada, Switzerland, Norway, Australia, China and the UK. LeMaitre Vascular is headquartered in Burlington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company LeMaitre Vascular Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

2
List of Tables 3
List of Figures 3
LeMaitre Vascular Inc Company Overview 4
LeMaitre Vascular Inc Company Snapshot 4
LeMaitre Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview 4
LeMaitre Vascular Inc Pipeline Analysis Overview 6
Business Description 6
LeMaitre Vascular Inc - Key Facts 7
LeMaitre Vascular Inc - Major Products and Services 8
LeMaitre Vascular Inc Pipeline Products by Development Stage 10
LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status 12
LeMaitre Vascular Inc Pipeline Products Overview 14
LifeSpan ePTFE Vascular Graft 14
LifeSpan ePTFE Vascular Graft Product Overview 14
NovaSil 15
NovaSil Product Overview 15
XenoSure Biologic Vascular Patch 16
XenoSure Biologic Vascular Patch Product Overview 16
XenoSure Biologic Vascular Patch Clinical Trial 17
LeMaitre Vascular Inc - Key Competitors 18
LeMaitre Vascular Inc - Key Employees 19
LeMaitre Vascular Inc - Key Employee Biographies 20
LeMaitre Vascular Inc - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
LeMaitre Vascular Inc, Recent Developments 23
Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%) 23
Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017 23
Oct 26, 2017: LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%) 24
Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 24
Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 25
Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 25
Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 26
Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) 26
May 02, 2016: LeMaitre Q1 2016 Sales $20.3mm (+7%), Op. Inc. $3.3mm (+43%) 27
Feb 24, 2016: LeMaitre Q4 2015 Record Sales $20.5mm (+14% organic), Record Net Income $2.5mm (+32%) 27
Appendix 29
Methodology 29
About GlobalData 31
Contact Us 31
Disclaimer 32

List Of Tables

List of Tables
LeMaitre Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview 4
LeMaitre Vascular Inc Pipeline Products by Equipment Type 5
LeMaitre Vascular Inc Pipeline Products by Indication 5
LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status 5
LeMaitre Vascular Inc, Key Facts 7
LeMaitre Vascular Inc, Major Products and Services 8
LeMaitre Vascular Inc Number of Pipeline Products by Development Stage 10
LeMaitre Vascular Inc Pipeline Products Summary by Development Stage 11
LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status 12
LeMaitre Vascular Inc Ongoing Clinical Trials Summary 13
LifeSpan ePTFE Vascular Graft - Product Status 14
LifeSpan ePTFE Vascular Graft - Product Description 14
NovaSil - Product Status 15
NovaSil - Product Description 15
XenoSure Biologic Vascular Patch - Product Status 16
XenoSure Biologic Vascular Patch - Product Description 16
XenoSure Biologic Vascular Patch - Random, Controlled, Single-blinded, Multi-center and Non-inferiority Clinical Study to Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair 17
XenoSure Biologic Vascular Patch - Random, Controlled, Single-blinded, Multi-center and Non-inferiority Clinical Study to Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Peripheral Vascular Repair 17
LeMaitre Vascular Inc, Key Employees 19
LeMaitre Vascular Inc, Key Employee Biographies 20
LeMaitre Vascular Inc, Other Locations 21
LeMaitre Vascular Inc, Subsidiaries 21
Glossary 30

List Of Figures

List of Figures
LeMaitre Vascular Inc Pipeline Products by Equipment Type 5
LeMaitre Vascular Inc Pipeline Products by Development Stage 10
LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status 12

LeMaitre Vascular Inc (LMAT) - Product Pipeline Analysis, 2018 Update

LeMaitre Vascular Inc (LeMaitre Vascular) provides medical devices and services for the treatment of peripheral vascular diseases. The company develops, manufactures, and markets both disposable and implantable devices that vascular

USD 750 View Report

LeMaitre Vascular Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

LeMaitre Vascular Inc Company Profile is a detailed strategic and analytical report on LeMaitre Vascular Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

LeMaitre Vascular Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

LeMaitre Vascular Inc Company Profile is a detailed strategic and analytical report on LeMaitre Vascular Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

LeMaitre Vascular Inc (LMAT) - Product Pipeline Analysis, 2017 Update

LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases.

USD 750 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available